US 9701674
Substituted pyrazines as ATR kinase inhibitors
granted A61PA61P35/00
Quick answer
US patent 9701674 (Substituted pyrazines as ATR kinase inhibitors) held by Vertex Pharmaceuticals Incorporated expires Mon Jul 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Jul 11 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 61
- CPC classes
- A61P, A61P35/00